Private Advisor Group’s OncoSec Medical Incorporated ONCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-477
Closed -$30K 2131
2021
Q2
$30K Hold
477
﹤0.01% 1951
2021
Q1
$50K Hold
477
﹤0.01% 1845
2020
Q4
$68K Hold
477
﹤0.01% 1713
2020
Q3
$35K Hold
477
﹤0.01% 1524
2020
Q2
$22K Hold
477
﹤0.01% 2535
2020
Q1
$13K Hold
477
﹤0.01% 1400
2019
Q4
$19K Hold
477
﹤0.01% 1608
2019
Q3
$21K Hold
477
﹤0.01% 1633
2019
Q2
$27K Buy
+477
New +$45.9K ﹤0.01% 1643

Other funds holding ONCS

Private Advisor Group's ONCS Position: Q3 2021 in Review

Private Advisor Group sold out of OncoSec Medical Incorporated (ONCS) in Q3 2021, closing a stake of 477 shares — an estimated $30K sold.

Private Advisor Group first reported a position in ONCS in Q2 2019 and held it in 9 quarters. The position peaked at $68K in Q4 2020. 31 funds tracked by Wall St. Rank hold ONCS as of Q3 2021.

  • Private Advisor Group reported no remaining OncoSec Medical Incorporated position as of Q3 2021 after selling out during the quarter.
  • Private Advisor Group sold 477 OncoSec Medical Incorporated shares in Q3 2021, an estimated $30K.
  • Private Advisor Group first reported a position in OncoSec Medical Incorporated in Q2 2019 and held it in 9 quarters.
  • Private Advisor Group's OncoSec Medical Incorporated position peaked at $68K in Q4 2020.
  • 31 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q3 2021.

Based on Private Advisor Group's 13F filing for Q3 2021, filed 14 Oct 2021.